4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-16-028530
CIK 0000806888operating
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 9:09 PM ET
Size
7.7 KB
Accession
0001437749-16-028530
Insider Transaction Report
Form 4
HOLLER ANTHONY F
Director
Transactions
- Award
Deferred Share Unit Award (Right to Receive)
2016-03-24+50,154→ 50,154 totalExercise: $0.00→ Common Stock (50,154 underlying) - Award
Stock Option (right to buy)
2016-03-24+5,000→ 5,000 totalExercise: $0.85Exp: 2026-03-23→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Reporting person has received an exempt award of Deferred Share Units ("DSUs") under the Issuer's Non-Employee Directors Deferred Share Unit Plan (the "Plan"). DSUs represent a right to receive shares of the issuer's common stock (or, in the sole discretion of the Issuer's Board of Directors following a Change in Control as defined in the Plan, cash, securities or a combination of cash and securities equal to the fair market value thereof) upon the reporting person's termination of service for the issuer. The DSUs are immediately vested and expire 90-days following the reporting person's Termination Date as defined in the Plan.
- [F2]Exercise prices shown are denominated in Canadian dollars.
- [F3]Subject to the reporting person's continued service as a director of the company through each vesting date, 100% of the shares subject to the option shall vest and become exercisable on March 24, 2017.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 9:09 PM ET
- Size
- 7.7 KB